The Weill Cornell Medicine-Qatar Institutional Review Board (WCM-Q IRB) reviews all human-subject research in which the institution is engaged.
WCM-NY and WCM-Q have valid Federal Wide Assurance (FWA) filed with the United States Office of Human Research Protections (OHRP). At the same time, both have valid assurances with the Ministry of Public Health in Qatar. WCM-NY and WCM-Q have written agreements to manage the regulatory oversight of research projects involving human subjects that are conducted jointly between faculty members. This agreement was initiated to facilitate collaboration and avoid the duplication of IRB reviews. WCM-Q's IRB serves as the IRB of record in most of the collaborative work that takes place in Qatar. However, in some instances WCM-NY's IRB review may be warranted. The IRB offices in Qatar and New York will guide the investigators through the process. Close coordination between both offices takes place to facilitate review and shorten the turnaround time.
The authorization agreement between the WCM-NYC and WCM-Q IRBs details the conditions for protocols conducted in collaboration between WCM NYC and WCM-Q.
WCM-Q IRB FAQs are available for internal users on our SharePoint site.
Office Contacts
Please contact irb@qatar-med.cornell.edu for information regarding submitting protocols to the WCM-Q IRB of record, or visit the WCM-Q Human Research Protection Program website.
Policies
Qatar Supreme Council of Health Policies, Regulations and Guidelines for Research Involving Human Subjects - Human subjects’ regulations from Health Research Governance Department – Ministry of Public Health (MoPH), Qatar.
WCM-NYC & WCM-Q IRB Authorization Agreement - The authorization agreement between the WCM-NYC and WCM-Q IRBs.